Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/524404 stock hub

BOM/524404 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/524404is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

89.6B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/524404

In the news

Latest news · BOM/524404

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19

P25 n/aP50 n/aP75 n/a

Trailing P/E24.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC13.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/524404 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

INR

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,840
Employees Change	699%
Employees Change Percent	61.26
Enterprise value	INR 86.5B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 89.6B
Price	INR 198
Price currency	INR
Rev Per Employee	15,235,228.26x
Sic	2834
Symbol	bom/524404
Website	https://marksanspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.02%
EV Earnings	24.01x
EV/EBIT	20.07x
EV/EBITDA	16.67x
EV/Sales	3.09x
Forward P/E	19.02x
P/B ratio	3.3x
P/E ratio	24.87x
P/S ratio	3.2x
PE Ratio10 Y	34.39x
PE Ratio3 Y	24.18x
PE Ratio5 Y	18.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.38%
EBITDA Margin	17.56%
Gross margin	54.83%
Gross Profit	INR 15.4B
Gross Profit Growth	13.45%
Gross Profit Growth Q	14.26%
Gross Profit Growth3 Y	20.32%
Gross Profit Growth5 Y	14.5%
Net Income	INR 3.6B
Net Income Growth	-2.17%
Net Income Growth Q	8.26%
Net Income Growth3 Y	19.29%
Net Income Growth5 Y	12.29%
Pretax Margin	17%
Profit Margin	12.85%
Profit Per Employee	INR 2M
Roa5y	11.22
Roe5y	19.82
ROIC	13.76
Roic5y	23.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.94%
Cagr15y	34.42%
Cagr1y	-11.98%
Cagr20y	11.54%
Cagr3y	37.67%
Cagr5y	22.25%
Div CAGR10	20.89%
Div CAGR3	16.96%
Div CAGR5	26.19%
EPS Growth	-2.25
EPS Growth Q	8.23
EPS Growth3 Y	14.65
EPS Growth5 Y	9.86
Revenue Growth	13.29x
Revenue Growth Q	10.65x
Revenue Growth3 Y	16.25x
Revenue Growth5 Y	15.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 6.7B
Debt	INR 3.3B
Debt EBITDA	INR 0.64
Debt Equity	INR 0.12
Equity	INR 27.1B
Interest Coverage	20.29
Net Cash	INR 3.4B
Net Cash By Market Cap	INR 3.74
Net Cash Growth	-29.24%
Net Debt EBITDA	INR -0.68
Net Debt Equity	INR -0.12
Tangible Book Value	INR 25.5B
Tangible Book Value Per Share	INR 56.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.11%
Dividend Growth	33.33%
Dividend Growth Years	3%
Dividend per share	INR 0.8
Dividend Years	12
Dividend Yield	0.43%
Ex Div Date	2025-08-01
Last Dividend	INR 0.8
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	302.52%
1Y total return	-11.97%
200-day SMA	183.4
3Y total return	160.98%
50-day SMA	175.9
50-day SMA vs 200-day SMA	50under200
5Y total return	173.06%
All Time High	358.5
All Time High Change	-44.8%
All Time High Date	2024-12-02
All Time Low	1.27
All Time Low Change	15,482.68%
All Time Low Date	2012-05-18
ATR	7.82
Ch YTD	9.85
High	205.9
High52	270.6
High52 Date	2025-06-11
High52ch	-26.87%
Low	197.3
Low52	156
Low52 Date	2026-03-30
Low52ch	26.86%
Ma50ch	12.53%
Price vs 200-day SMA	7.93%
RSI	62.95
RSI Monthly	52.08
RSI Weekly	58.88
Sharpe ratio	-0.24x
Sortino ratio	-0.2
Total Return	0.32%
Tr YTD	9.85
Tr15y	8,348.97%
Tr1m	16.41%
Tr1w	4.79%
Tr3m	11.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 4.3B
Operating Income Growth	0.07
Operating Income Growth Q	15.53
Operating Income Growth3 Y	22.57
Operating Income Growth5 Y	9.5
Operating margin	15.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	214,463,366%
Shares Insiders	43.87%
Shares Institutions	12.14%
Shares Qo Q	0.01%
Shares Yo Y	0.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	69,010.85x
Bv Per Share	59.37
Ch10y	290.7
Ch15y	8,077.7
Ch1m	16.41
Ch1w	4.79
Ch1y	-12.28
Ch20y	760.4
Ch3m	11.71
Ch3y	158.1
Ch5y	167.8
Ch6m	8.29
Change	-2.58%
Change From Open	-3.44
Close	203.2
Days Gap	0.89
Depreciation Amortization	610,345,000
Dollar Volume	18,964,757
Earnings Date	2026-05-19
EBIT	INR 4.3B
EBITDA	INR 4.9B
EPS	INR 7.95
F Score	2
Fiscal Year End	March
Founded	1,992
Graham Number	103.57528
Graham Upside	-47.66
Income Tax	INR 1.1B
Is Primary Listing	0
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Last Split Date	2008-03-11
Last Split Type	Forward
Lynch Fair Value	INR 97.83
Lynch Upside	-50.57
Ma150	178.8
Ma150ch	10.66%
Ma20	185.4
Ma20ch	6.74%
Next Earnings Date	2026-05-19
Open	205
Payment Date	2025-09-07
Position In Range	7.51
Price Date	2026-05-08
Price EBITDA	INR 18.21
Ptbv Ratio	3.51
Relative Volume	1.39x
Revenue	28,032,820,000x
Tax By Revenue	4.1x
Tax Rate	24.1%
Tr20y	788.98%
Tr6m	8.29%
Volume	95,830

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/524404 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.80 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+26.2%

3 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-08-01

Performance

BOM/524404 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/524404?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.1%

Share of float held by funds and institutions

Insider ownership

+43.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

BOM/524404 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.9

Neutral momentum band

Price vs 200-day MA

+7.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/524404

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/524404 stock rating?

bom/524404 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/524404 analysis?

The full report lives at /stocks/bom/524404/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/524404?

The latest report frames bom/524404 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/524404 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.